Integer (NYSE:ITGR) Receives “Overweight” Rating from Piper Sandler

Integer (NYSE:ITGR)‘s stock had its “overweight” rating reiterated by stock analysts at Piper Sandler in a report issued on Friday,Benzinga reports. They presently have a $97.00 price target on the medical equipment provider’s stock, up from their prior price target of $87.00. Piper Sandler’s target price indicates a potential upside of 15.18% from the company’s previous close.

ITGR has been the topic of several other reports. Truist Financial upped their price objective on shares of Integer from $95.00 to $97.00 and gave the company a “buy” rating in a report on Friday, February 20th. Wall Street Zen downgraded shares of Integer from a “buy” rating to a “hold” rating in a report on Sunday, January 25th. Wells Fargo & Company upped their price objective on shares of Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a report on Friday, February 20th. Citigroup upped their price objective on shares of Integer from $75.00 to $92.00 and gave the company a “neutral” rating in a report on Friday, February 20th. Finally, Weiss Ratings raised shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 24th. Four research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $98.71.

Integer Stock Performance

Integer stock traded down $4.30 during mid-day trading on Friday, reaching $84.22. 384,167 shares of the company traded hands, compared to its average volume of 738,792. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.32 and a quick ratio of 2.23. Integer has a fifty-two week low of $62.00 and a fifty-two week high of $126.86. The company has a market capitalization of $2.87 billion, a price-to-earnings ratio of 29.43, a price-to-earnings-growth ratio of 1.42 and a beta of 0.71. The firm’s fifty day moving average is $86.07 and its two-hundred day moving average is $81.76.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). Integer had a net margin of 5.55% and a return on equity of 13.26%. The company had revenue of $439.58 million for the quarter, compared to analyst estimates of $426.48 million. During the same quarter in the previous year, the company posted $1.31 EPS. The company’s revenue for the quarter was up .5% compared to the same quarter last year. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. On average, equities research analysts expect that Integer will post 6.47 earnings per share for the current fiscal year.

Insider Buying and Selling at Integer

In other news, VP Tommy P. Thomas sold 825 shares of the firm’s stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $85.00, for a total value of $70,125.00. Following the transaction, the vice president directly owned 4,381 shares of the company’s stock, valued at approximately $372,385. This trade represents a 15.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Integer

Hedge funds and other institutional investors have recently bought and sold shares of the company. William Blair Investment Management LLC acquired a new stake in shares of Integer during the third quarter valued at about $28,459,000. Public Sector Pension Investment Board increased its position in shares of Integer by 14.9% during the third quarter. Public Sector Pension Investment Board now owns 136,632 shares of the medical equipment provider’s stock valued at $14,118,000 after acquiring an additional 17,699 shares during the last quarter. Magnetar Financial LLC acquired a new stake in shares of Integer during the third quarter valued at about $1,890,000. New York State Common Retirement Fund increased its position in shares of Integer by 12.0% during the third quarter. New York State Common Retirement Fund now owns 267,613 shares of the medical equipment provider’s stock valued at $27,652,000 after acquiring an additional 28,650 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA acquired a new stake in shares of Integer during the third quarter valued at about $41,938,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Key Integer News

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Revenue and organic growth beat expectations — Q1 sales were roughly $440M (up 0.5% year-over-year) with 1.3% organic growth, driven by strength across key product lines. This topline beat is supporting optimism on demand recovery. ITGR Stock Up Despite Q1 Earnings Missing Estimates, Revenues Rise Y/Y
• Neutral Sentiment: Board has initiated a strategic review to “maximize stockholder value” (including possible sale, merger or other combinations). A review can unlock value but also creates execution and process uncertainty; outcomes are binary and timing is unclear. Integer Announces Strategic Review to Maximize Stockholder Value
• Neutral Sentiment: Company published the full Q1 release, slide deck and held its earnings call (transcript and presentation available). These materials provide detail on segment trends and margin drivers for investors doing deeper diligence. Integer Holdings Corporation 2026 Q1 – Results – Earnings Call Presentation
• Neutral Sentiment: Trading was temporarily halted pre-market on the day of the release for “news pending,” which typically increases short-term volume and volatility once resumed. Integer Announces Strategic Review to Maximize Stockholder Value
• Negative Sentiment: EPS missed consensus by a penny — reported $1.20 vs. $1.21 expected — and year-over-year EPS declined from $1.31, reflecting margin pressure that investors are watching closely. Integer (ITGR) Q1 Earnings Lag Estimates
• Negative Sentiment: FY 2026 EPS guidance was set to $5.83–$6.40, below the consensus (~$6.49), which raises investor concern about margin recovery and near-term earnings growth — a key reason for today’s downside pressure. Integer Q1 2026 Press Release / Guidance

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.